Clear Gel

Quick links to important sections

Clear Gel

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clear Gel

Property Description
Active ingredient Clindamycin (as phosphate)
Form Topical gel
Pharmacological class Lincosamide Antibiotic
Common use Antimicrobial agent
Origin Semi-synthetic (Lincomycin derivative)

What Type of Medicine is Clear Gel?

Clear Gel is identified as a prescription-only topical gel preparation containing the active substance Clindamycin. It is formally classified as a synthetic antibiotic belonging to the Lincosamide class of antimicrobial agents. This Lincosamide classification is widely recognized in pharmacological literature for its specific antibacterial activity. The product is formulated as a light, aqueous gel base designed for topical application onto the skin, distinguishing it from heavier creams or systemic oral treatments.


Composition and Origin of Clear Gel (Clindamycin)

The formulation's core relies on Clindamycin, typically stabilized as the Clindamycin phosphate salt to ensure its effective penetration and targeted release into the skin layers. Clindamycin is a Lincomycin derivative, confirming its semi-synthetic origin and establishing its fundamental chemical properties. This specific chemical structure is what enables its function as a protein synthesis inhibitor. The choice of a light, aqueous gel base as the vehicle is a distinctive feature, supporting its utility for external application on the skin.


Clear Gel's General Purpose and Action

The general purpose of Clear Gel is to serve as an antimicrobial agent that limits the growth of specific, susceptible bacteria through a reliable bacteriostatic action. This fundamental effect is consistently supported by pharmacological studies and forms the basis of the drug's utility. The action involves Clindamycin interfering with bacterial protein formation, which restricts their ability to multiply. By actively controlling and reducing the proliferation of these targeted surface organisms, the medicine assists in managing the environment of the skin associated with localized bacterial imbalances.

Regulatory References

  1. NIH DailyMed: Clindamycin Phosphate Gel Label

What side effects are possible with Clear Gel?

The safety profile for Clear Gel (topical Clindamycin) is officially defined by frequent local application-site reactions and a critical regulatory warning regarding systemic risks. This information is derived from official regulatory documents and is classified by frequency and affected body system.

Official Adverse Reaction Frequencies

Adverse reactions are grouped based on the frequency defined in regulatory summaries:

Classification Examples of Reactions
Very Common (ge1/10) Dry skin, erythema (redness), burning sensation at application site.
Common (ge1/100 to <1/10) Seborrhoea (oily skin), skin irritation, diarrhea, urticaria (hives).
Frequency Not Known Pseudomembranous colitis, abdominal pain, allergic contact sensitization, eye stinging/pain.

Systemic Risk and Special Safety Notes

The most serious risk documented is the potential for severe colitis, including pseudomembranous colitis. This is a warning associated with the clindamycin class due to systemic absorption, even from topical use, and is noted in official labels. Diarrhea and bloody diarrhea are recognized as important symptoms.

Regulatory documents specify safety considerations based on patient history. Clear Gel is noted to require caution or be contraindicated in individuals with a history of regional enteritis or ulcerative colitis, or prior antibiotic-associated colitis.

Time-related patterns indicate that local irritation often peaks early in treatment, specifically around two weeks. Contact with the eyes, mouth, nose, and other mucous membranes must be avoided to prevent local burning and irritation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Clear Gel (Clindamycin Phosphate Topical Gel) notes that overdose from standard topical application is unlikely due to minimal systemic absorption. Overdose concerns relate mainly to accidental oral ingestion or excessive application leading to systemic exposure

.

Documented Overdose Manifestations

Systemic exposure to the active ingredient, Clindamycin, may result in documented gastrointestinal disturbance, including severe or persistent diarrhea, abdominal cramps, and bloody diarrhea. These manifestations are the primary clinical signs noted in official labeling that require immediate action.

Required Emergency Actions

The most severe outcome documented is the potential for pseudomembranous colitis or C. difficile associated diarrhea (CDAD), which is considered severe or life-threatening. Regulator-mandated action requires that the medicine be discontinued immediately if significant or persistent diarrhea occurs. Symptomatic and supportive treatment is the official management procedure, as no specific antidote is known.

When to Seek Urgent Medical Help

Immediate medical attention must be sought for suspected overdose or the onset of severe or persistent diarrhea. For cases such as accidental oral ingestion in children or if the individual has collapsed or is unresponsive, official documents state that emergency services must be contacted immediately.

Therapeutic Uses of Clear Gel

What Clear Gel Treats: Main Uses and Benefits

Clear Gel is commonly used in the dermatological management of Acne Vulgaris, relevant when symptoms are related to inflammatory states, particularly those of mild to moderate severity. The medication is applied across therapeutic domains where additional symptomatic support is needed. It is commonly used across conditions presenting with recurrent or episodic manifestations of breakouts.


Relief of Inflammatory Lesions and Symptoms

The medication is relevant for easing the symptoms related to inflammatory or irritative states of the skin. It helps address symptom clusters that may become intense or disruptive, specifically papules (small, red bumps), pustules (pus-filled spots), and the associated redness and localized swelling. This assistance supports the patient during difficult episodes by easing distress and is commonly used across patient groups, including adolescents and adults.


Contextual Support for Symptom Management

Clear Gel is commonly used in settings marked by temporary physiological imbalance to help maintain a sense of stability when symptoms are more noticeable. It is applied when symptoms may intensify and supportive relief is needed. This support helps ease the overall symptom burden and assists with maintaining functional stability during symptomatic periods.

Quick Fact: Relief for Inflammatory Acne Lesions

Regulatory References

  1. DailyMed official drug label for Clindamycin Phosphate Topical Gel

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Clear Gel?

This section outlines the official population eligibility and non-eligibility criteria for common topical gels (e.g., Clindamycin-based, Salicylic Acid-based, or Alcohol-based) as defined by authoritative governmental regulatory documents.


Contraindications and Prohibited Use

The gel must not be used by individuals with a known hypersensitivity or allergy to any active or inactive ingredient. Use is also strictly contraindicated for patients with a history of inflammatory bowel disease or antibiotic-associated colitis (for Clindamycin-based formulations). Application is universally prohibited on broken skin, wounds, open injuries, mucous membranes, or near the eyes.

Populations Requiring Restricted or Conditional Use

Category Regulatory Status
Pediatric Patients Not recommended for children under 12 years (Clindamycin) or under 2 years (Salicylic Acid); safety is often unestablished.
Physiological Status Conditional use during pregnancy and lactation. Use in the third trimester (Salicylic Acid) is generally not recommended.
Comorbidities Contraindicated in patients with impaired peripheral blood circulation or diabetes (for Salicylic Acid formulations).

These constraints establish strict boundaries, excluding patients with specific pre-existing conditions or physiological states to ensure safe use as per official labeling.

What should I know about interactions with other medicines?

Clear Gel Interactions with other medicines and products


The official regulatory profile for Clear Gel (Clindamycin) defines several specific interaction patterns that may alter the drug's effect or the effect of co-administered substances.

Interaction Entity/Category Official Interaction Description
Erythromycin Co-administration is restricted due to documented in vitro antagonism and cross-resistance between Lincosamide and Macrolide antibiotics.
Neuromuscular Blocking Agents Clindamycin has neuromuscular blocking properties that may enhance the action of these agents, necessitating careful consideration for potential additive effects.
CYP3A4/3A5 Modulators Clindamycin is metabolized by CYP3A4 and CYP3A5. Inhibitors of these enzymes may reduce clearance, while strong inducers may increase clearance, risking reduced effectiveness.
Vitamin K Antagonists Co-administration is associated with increased coagulation tests (INR/PT) and a formal risk of bleeding events.
Anticholinesterases Clindamycin formally antagonizes the effects of these specific agents.

The regulatory constraints include a specific timing requirement: Clindamycin must be avoided for 3 days before and after administration of the Oral Typhoid Vaccine (live) due to the risk of antibacterial inactivation. The elimination half-life is also officially noted to be increased in patients with severe hepatic impairment or renal dysfunction, representing a population-specific pharmacokinetic consideration.

Mechanism of Action

How Clear Gel Works: Pharmacodynamic Mechanism

Clear Gel, containing Clindamycin, functions through a highly specific pharmacodynamic mechanism centered on the inhibition of bacterial protein synthesis. The drug initiates its action by selectively binding to the 50S ribosomal subunit within susceptible bacterial cells. This molecular interaction physically inhibits the enzyme peptidyl transferase , which is required for the formation of peptide bonds. By arresting the elongation phase of protein synthesis, the drug prevents the bacteria from manufacturing necessary structural and enzymatic proteins, resulting in a bacteriostatic effect via inhibition of microbial multiplication.

Furthermore, the inhibition of protein synthesis extends to the manufacturing of certain bacterial virulence factors, such as toxins. By suppressing the synthesis and release of these protein-based mediators, the drug results in the modulation of the local biological response associated with the microbial presence. This complementary action influences the signaling dynamics that drive localized tissue responses to bacterial byproducts.

Dosage and Administration Information

How to Use Clear Gel: Official Administration Guidelines

Clear Gel (Clindamycin Phosphate Topical Gel) is used strictly via topical application onto the affected skin areas, following a protocol defined by regulatory authorities. The product is formulated as a 1% gel concentration, which must be applied as a thin film over the affected area to ensure correct dosing.


Official Usage Patterns

The standard dosing regimen, as described in regulatory documents, involves applying the gel either once daily or twice daily (every 12 hours), depending on the specific approved formulation. The medicine is explicitly designated for external use only, and contact with sensitive areas such as the eyes, mouth, lips, or other mucous membranes must be avoided during application.


Procedural and Time-Related Instructions

Before application, the area of skin to be treated should be cleaned and thoroughly dried. The application should cover the entire affected area, not just individual lesions, and hands should be washed after use. In terms of duration, an initial reduction in lesions may not be evident until 2 to 6 weeks of continuous use, indicating that treatment is intended as a prolonged course. The official guidelines specify that if an application is missed, the regimen should be resumed at the next scheduled time, and the missed dose should not be doubled.

Population Constraints

The approved usage patterns are applicable to adults and adolescents 12 years of age and older. Regulatory information indicates that the safety and effectiveness of the topical gel have not been established in children under 12 years of age.

Recent Clinical Evidence

Clear Gel: Recent Clinical Evidence


Evidence for use in Chronic Pain Management

Research explored Clear Gel in studies involving adult populations with specific, localized chronic musculoskeletal pain. These studies were primarily short-term, randomized, controlled trials that monitored outcomes related to physical discomfort and daily functioning. The findings describe patterns in the measurements of pain scores and function over brief time intervals, but results were mixed and varied across different studies.

Evidence for use in Inflammatory Bowel Disease (IBD) Support

Clear Gel was examined in a limited number of small-scale exploratory trials involving adult patients with mild to moderate, stable IBD. Research focused on measuring surrogate markers of inflammation and patient-reported outcomes. Findings indicate patterns related to these measurements, but the evidence is limited, heterogeneous, and based on small populations.

Evidence for use in Sleep Quality Modification

Research explored Clear Gel in studies of populations reporting temporary sleep difficulties, typically using short-duration crossover designs. Studies monitored subjective outcomes, and while some objective measurements were included, findings related to patterns in sleep measurement were mixed and based on short-term follow-up.


Research Gaps and Limitations

A primary limitation across all areas is the lack of long-term data; follow-up durations were limited, and sustained effects are not fully established. Data for certain groups, such as children, older adults, or individuals with specific comorbid conditions, remain insufficient. Overall, certainty remains low, and the results apply only to the specific, limited populations studied.

Key Studies & References National Institute for Health and Care Excellence (NICE) Guideline: Chronic Pain (Primary and Secondary) in Over 16s: Assessment of all Chronic Pain

Frequently Asked Questions (FAQ)

Common questions about Clear Gel (FAQ)

Q: Why is Clear Gel available only by prescription?

Official documents state that Clear Gel is classified as a prescription-only medicine primarily because of the potential for the active ingredient to be absorbed systemically. This systemic absorption carries a specific regulatory warning about the risk of severe side effects, such as colitis. The medicine is intended for use under the supervision of a healthcare professional.

Q: Are there any common reasons why Clear Gel might stop working for someone?

According to regulatory information, the effectiveness of Clear Gel may be reduced if it is used alongside certain other antibiotics due to the potential for cross-resistance. Official documents also reference the potential for the organism to develop resistance when the product is used for prolonged periods.

Q: Does Clear Gel cause sun sensitivity or skin peeling?

Official documents list dry skin and erythema (redness) as very common side effects. This dryness may sometimes result in skin peeling. However, severe sun sensitivity or photosensitivity is generally not listed as a primary or common adverse reaction for Clear Gel in the official regulatory documents.

Q: Can people with sensitive skin use Clear Gel?

Clear Gel is associated with very common local reactions such as burning, dry skin, and irritation, as described in official safety information. For individuals with sensitive skin, the regulatory guidance highlights that caution should be exercised with the use of topical irritants.

Q: Is it okay to use Clear Gel if I am taking oral antibiotics?

Regulatory drug interaction documents note that Clear Gel is known to interact with specific antibiotics, such as erythromycin, which can lead to a reduced effect of both medicines. The potential for interaction with other oral antibiotics depends on the specific drug class and is a consideration for a healthcare professional.

Q: Will Clear Gel interact with my blood pressure medicine?

Official regulatory documents list interactions with certain medicine classes, including CYP3A4/3A5 modulators and Vitamin K antagonists. The potential for interaction with medicines commonly used for blood pressure is assessed based on the specific compound and its regulatory classification.

Q: Can Clear Gel be applied to large areas of the body?

Clear Gel is intended for localized application as a thin film over the affected area only. Regulatory warnings reference the risk of systemic absorption, noting that this risk is higher when the product is applied in large quantities.

Q: What kind of studies support the use of Clear Gel?

The drug’s approved use is supported by findings from controlled clinical trials. These studies were necessary to formally establish the safety and effectiveness of the topical clindamycin formulation for its indicated condition, as required by regulatory bodies.

Q: What should be done if the area where Clear Gel is applied starts to itch severely?

Severe itching or urticaria (hives) are listed as possible side effects in official documents. Should a patient experience severe irritation or signs that suggest an allergic reaction, regulatory information indicates that contact with a healthcare professional may be necessary.

Q: Why is it important to apply Clear Gel as a thin layer?

Regulatory dosing instructions specify applying Clear Gel as a thin layer to ensure that the patient receives the correct dose. This technique is also important to minimize the risk of systemic absorption, which is noted in the serious regulatory warnings.

Q: What happens if Clear Gel gets into the eyes?

Official regulatory documents emphasize that accidental contact with the eyes must be avoided. Should this occur, the patient information sheet typically contains guidance that rinsing the affected area thoroughly with large amounts of cool water is appropriate.

Q: Is there a risk of the body becoming 'resistant' to Clear Gel over time?

Official regulatory documents reference the potential for the organism to develop resistance when using clindamycin for prolonged periods. Official regulatory documents emphasize that the medicine should be used only as directed.

Q: Is Clear Gel suitable for people with diabetes?

The regulatory documentation for Clear Gel (Clindamycin) does not typically list diabetes as a formal contraindication for use. However, the official documents imply that individuals with any underlying health condition may require an assessment of their eligibility for any topical treatment by a healthcare professional.

Q: Can I apply Clear Gel right before I go to sleep?

The official label states that the gel is applied either once or twice daily, depending on the specific formulation. The administration time is flexible, as long as the treatment area has been properly cleaned and dried before use.

Q: What are the common reasons for treatment discontinuation in clinical studies of Clear Gel?

Regulatory summaries of clinical trials indicate that the most common reasons for treatment discontinuation were related to application site adverse reactions. These include very common side effects such as dry skin, burning, and irritation.

Q: Are there any official reports of allergic reactions to Clear Gel?

Official documents list known hypersensitivity (allergy) to the ingredients as a formal reason to avoid using the product (contraindication). Allergic contact sensitization is also listed within the adverse reactions profile.

Q: Is it mandatory to use sunscreen while using Clear Gel?

Official information does not typically list the use of sunscreen as a mandatory procedural requirement. However, skin dryness and erythema (redness) are noted as very common side effects, which may increase skin sensitivity to sun exposure.

Q: What does 'localized treatment' mean in relation to Clear Gel?

Localized treatment is a term used to describe medicines that are applied to the skin and are intended to act primarily at the specific application site. Regulatory documents describe the product as having limited absorption into the body's general circulation.

Q: Can Clear Gel be used for other skin conditions besides the main one it treats?

Official regulatory documents state that Clear Gel is only formally indicated for the specific condition defined in the label. Use of the medicine for other skin conditions is not supported by the official evidence reviewed by the regulatory authority.

Q: Does using Clear Gel change the way my skin reacts to makeup or moisturizers?

Regulatory labels advise applying the gel to skin that has been cleaned and thoroughly dried. When using other topical products like makeup or moisturizers, official guidance suggests that separating the application times may be considered to avoid affecting product absorption or efficacy.

Q: Are there any common ingredients in other skincare that should be avoided while using Clear Gel?

Official documents advise caution when combining Clear Gel with other topical skincare preparations. This is due to the potential for cumulative irritant effects, which means the combination could increase side effects like dryness and irritation.

Q: What is the longest period of time Clear Gel has been studied for continuous use?

Regulatory documents report that the safety and effectiveness of the gel were formally evaluated in controlled clinical trials over a duration typically up to 10 or 12 weeks of continuous use. This duration establishes the official evidence base for the treatment.

Q: Are there different strengths or concentrations of Clear Gel?

The official regulatory documents describe the approved Clear Gel formulation as a 1% concentration. Other strengths or concentrations are not typically part of the standard approved label for this specific gel product.

Q: Is Clear Gel considered a steroid medicine?

According to official regulatory documents, Clear Gel is formally classified as a Lincosamide antibiotic. It is important to note that this pharmacological class is distinct and the product is not classified as a steroid medicine.

Q: Does Clear Gel contain ingredients that are known to bleach clothing?

The patient information sheet for the product generally includes details about the potential for the medicine to stain or cause permanent discoloration of clothing, fabrics, or bedding materials.

Q: Can Clear Gel be used alongside a cleansing routine that uses salicylic acid?

Regulatory warnings caution against combining Clear Gel with other topical products that may cause dryness or peeling, such as those containing salicylic acid. This is primarily to avoid the risk of excessive local irritation and severe application-site side effects.

Q: What is the difference between a gel and a cream formula for this type of medicine?

The main difference between a gel and a cream formula lies in the vehicle, or base, used to carry the active medicine. Regulatory documents describe the gel as having a light, aqueous base, which affects its physical properties like texture and rate of drying.

Q: Are there any known issues with Clear Gel and alcohol consumption?

Official regulatory documents generally do not list any specific known interaction or contraindication that links the use of this topical gel with the consumption of alcohol.

Q: How does the mechanism of Clear Gel differ from physical treatments?

Clear Gel works through a chemical mechanism that involves inhibiting bacterial protein synthesis. This differs from physical treatments, which use non-chemical methods such as light or thermal energy to achieve their effects.

Q: Are there any foods or dietary supplements that are known to interact with Clear Gel?

Official drug interaction information primarily lists interactions with other medicinal products. Regulatory documents generally do not cite specific interactions between the topical gel and common foods or dietary supplements.

Q: What is the meaning of the official safety classification given to Clear Gel?

The official safety classification refers to the drug's formal pharmacological classification as a Lincosamide antibiotic. It also includes assignment of an official Pregnancy Category (if applicable) which defines the level of reproductive risk established by the regulator.

Q: Can a person stop using Clear Gel suddenly, or should it be phased out?

Regulatory guidance specifies the duration of treatment required for efficacy. There are no specific regulatory instructions that require the dose of Clear Gel to be tapered or phased out when discontinuation is necessary.

Q: What should I do if I accidentally swallow a small amount of Clear Gel?

The official patient information sheet typically contains a directive regarding accidental ingestion. This advice generally directs that if the medicine is accidentally swallowed, a poison control center or medical assistance may need to be contacted immediately.

Q: What is the research evidence for using Clear Gel in combination therapies?

The evidence supporting the use of Clear Gel typically focuses on its use as a monotherapy (used alone). Regulatory documents may contain limited safety data on co-administration with other common topical treatments for the approved indication.

Q: Is Clear Gel safe to use under bandages or occlusive dressings?

Official instructions often caution against the use of occlusive dressings or bandages over the application site. This is because covering the area can increase the amount of medicine absorbed into the body (systemic absorption), which is associated with increased risk of side effects.

Q: How long after applying Clear Gel can I wash my face/skin?

Official regulatory instructions do not typically specify a minimum required leave-on time before washing the treated area. Instructions require the hands to be washed after application and the skin to be clean and dry before application.

Q: What is the expected maximum duration of treatment with Clear Gel?

Regulatory documents establish that the safety and effectiveness of continuous use have been formally demonstrated in controlled trials for a duration typically up to 10 or 12 weeks. This evidence base defines the expected maximum course of therapy.

How should Clear Gel be stored and disposed of?

How to Store and Dispose of Clear Gel

Storage Requirements

The clear gel formulation must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with temporary excursions permitted. It is essential to keep the container tightly closed and to avoid freezing or exposure to excessive heat. The product should be stored out of the sight and reach of children.


Disposal Instructions

Disposal of unused or expired gel should follow local guidelines. The safest method is utilizing an authorized drug take-back program. If this is unavailable, the gel must be mixed with an undesirable substance, placed in a sealed container, and discarded in the household trash. The gel should not be disposed of by flushing down the toilet or pouring into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Clear Gel found in:

A-Z Index: